Vertex Pharmaceuticals Incorporated
VRTXLast close · Oct 16, 2026499.74−9.01 (−1.77%)
Market cap$126.7B
Between May 1, 2026 and Sep 8, 2026, Vertex Pharmaceuticals (VRTX) insiders filed 40 Form 4 transactions: 13 sales worth $10.9M in total and no open-market purchase; 13 of the sales were under 10b5-1 plans set in advance. The largest seller was Bozic Carmen, $3.1M. 27 other filings were grants, exercises or gifts, which say nothing about buying or selling.
40
0
13
14
Form 4 transactions
| Date | Insider | Title | Code | Plan | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| 2026-09-08 | van Grunsven Jasper | EVP, CP and NPPO | A | 8,682 | 0.00 | $0 | |
| 2026-08-28 | Ambrose Kristen | SVP & Chief Accounting Officer | A | 5,000 | 0.00 | $0 | |
| 2026-08-27 | SACHS BRUCE I | Director | G | 6,000 | 0.00 | $0 | |
| 2026-07-21 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A | 8,251 | 0.00 | $0 | |
| 2026-07-21 | Sachdev Amit | EVP Chief Patient & Ext Af Off | A | 8,251 | 0.00 | $0 | |
| 2026-07-15 | SACHS BRUCE I | Director | A | 100 | 475.28 | $47,500 | |
| 2026-07-15 | Garber Alan M | Director | A | 32 | 475.28 | $14,999.8 | |
| 2026-07-02 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | 10b5-1 | 1,500 | 524.99 | $787,485 |
| 2026-07-02 | McKechnie Duncan | EVP, Chief Commercial Officer | S | 10b5-1 | 1,541 | 519.00 | $799,779 |
| 2026-07-01 | Liu Joy | EVP and Chief Legal Officer | S | 10b5-1 | 828 | 502.71 | $416,243.9 |
| 2026-06-26 | Bozic Carmen | EVP and CMO | S | 10b5-1 | 596 | 482.50 | $287,570 |
| 2026-06-18 | Bozic Carmen | EVP and CMO | S | 10b5-1 | 1,020 | 462.17 | $471,413.4 |
| 2026-06-15 | Bozic Carmen | EVP and CMO | S | 10b5-1 | 4,062 | 450.00 | $1.8M |
| 2026-06-05 | Bozic Carmen | EVP and CMO | S | 10b5-1 | 1,745 | 450.00 | $785,250 |
| 2026-06-01 | Liu Joy | EVP and Chief Legal Officer | S | 10b5-1 | 828 | 439.91 | $364,245.5 |
| 2026-05-29 | Bozic Carmen | EVP and CMO | S | 10b5-1 | 1,974 | 450.00 | $888,300 |
| 2026-05-15 | Bunnage Mark E. | EVP, Chief Scientific Officer | S | 10b5-1 | 33 | 453.45 | $14,963.9 |
| 2026-05-15 | Bozic Carmen | EVP and CMO | S | 10b5-1 | 1,354 | 453.45 | $613,971.3 |
| 2026-05-12 | Bozic Carmen | EVP and CMO | S | 10b5-1 | 6,988 | 450.00 | $3.1M |
| 2026-05-01 | Upadhyay Suketu | Director | D | 796 | — | — | |
| 2026-05-01 | Upadhyay Suketu | Director | A | 2,866 | 0.00 | $0 | |
| 2026-05-01 | Upadhyay Suketu | Director | A | 796 | — | — | |
| 2026-05-01 | Thornberry Nancy | Director | A | 472 | 0.00 | $0 | |
| 2026-05-01 | Thornberry Nancy | Director | D | 398 | — | — | |
| 2026-05-01 | Thornberry Nancy | Director | A | 1,433 | 0.00 | $0 | |
| 2026-05-01 | Thornberry Nancy | Director | A | 398 | — | — | |
| 2026-05-01 | Schneider Jennifer | Director | A | 472 | 0.00 | $0 | |
| 2026-05-01 | Schneider Jennifer | Director | D | 796 | — | — | |
| 2026-05-01 | Schneider Jennifer | Director | A | 1,433 | 0.00 | $0 | |
| 2026-05-01 | Schneider Jennifer | Director | A | 796 | — | — | |
| 2026-05-01 | SACHS BRUCE I | Director | A | 2,866 | 0.00 | $0 | |
| 2026-05-01 | MCKENZIE DIANA | Director | A | 943 | 0.00 | $0 | |
| 2026-05-01 | MCKENZIE DIANA | Director | D | 796 | — | — | |
| 2026-05-01 | MCKENZIE DIANA | Director | A | 796 | — | — | |
| 2026-05-01 | Liu Joy | EVP and Chief Legal Officer | S | 10b5-1 | 1,104 | 425.02 | $469,222.1 |
| 2026-05-01 | Lagarde Michel | Director | A | 2,866 | 0.00 | $0 | |
| 2026-05-01 | Garber Alan M | Director | A | 472 | 0.00 | $0 | |
| 2026-05-01 | Garber Alan M | Director | A | 1,433 | 0.00 | $0 | |
| 2026-05-01 | CARNEY LLOYD | Director | A | 2,866 | 0.00 | $0 | |
| 2026-05-01 | Bhatia Sangeeta N. | Director | A | 10b5-1 | 943 | 0.00 | $0 |
Codes are the SEC's: P open-market purchase, S open-market sale; M exercise, F tax withholding, A grant and G gift are routine. A 10b5-1 flag means the trade ran under a plan adopted in advance. Method notes in where the numbers come from.